Real-world Data (RWD) Market

Real-world Data (RWD) Market, By Source (Electronic health records (EHRs), Claims data, Pharmacy data, Patient-reported outcomes (PROs), Disease registries, Other sources), By Application (Drug development and approvals, Market access and reimbursement/coverage decisions, Post-market surveillance, Clinical research, Other applications), By End User (Pharmaceutical and medical device companies, Healthcare payers, Healthcare providers, Government agencies, Other end users), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Real world data plays a crucial role in understanding and addressing complex challenges across various fields. It refers to information gathered from real-life situations, such as demographics, economic indicators, healthcare records, environmental factors and more. Unlike simulated or theoretical data, real world data offers insights into actual events, behaviours and trends. It enables researchers, policymakers and businesses to make informed decisions, develop accurate models, and implement effective strategies. With the advent of advanced technologies and the growing availability of large-scale data, real world data analysis has become increasingly valuable in uncovering patterns, identifying correlations and generating actionable knowledge to drive innovation and improve outcomes in diverse domains.

Market Dynamics:

Increasing adaption of Electronic Health Records (EHRs), Growing demand for evidence-based medicine, Regulatory support and guidance is anticipated to drive growth of the Real World Data (RWD) market over the forecast period. Moreover, Advancements in Data Analytics and Technologies is also expected to boost the growth of the global Real World Data (RWD) market over the forecast period. Drug development and clinical trials, comparative effectiveness research, market access and reimbursement, pharmacovigilance and drug safety monitoring are expected to create growth opportunities for the global Real World Data (RWD) market during the forecast period.

However, data quality and completeness, data privacy and regulatory compliance, data fragmentation and interoperability and selection bias and generalizability are expected to hamper growth of the Real World Data (RWD) market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the Real World Data market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Real World Data market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include IQVIA Holdings Inc., Optum, Inc. (a subsidiary of UnitedHealth Group), Cerner Corporation, Flatiron Health, Inc. (a subsidiary of Roche), IBM Corporation, Tempus Labs Inc., Syneos Health Inc., Evidera, Inc., Palantir Technologies Inc., SAS Institute Inc.,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Real World Data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Real World Data market

Detailed Segmentation:

• Global Real World Data Market, By Source:
• Electronic health records (EHRs)
• Claims data
• Pharmacy data
• Patient-reported outcomes (PROs)
• Disease registries
• Other sources
• Global Real World Data Market, By Application:
• Drug development and approvals
• Market access and reimbursement/coverage decisions
• Post-market surveillance
• Clinical research
• Other applications
• Global Real World Data Market, By End User:
• Pharmaceutical and medical device companies
• Healthcare payers
• Healthcare providers
• Government agencies
• Others
• Global Real World Data Market, By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & South Africa
• Company Profiles:
• IQVIA Holdings Inc.
• Optum, Inc. (a subsidiary of UnitedHealth Group)
• Cerner Corporation
• Flatiron Health, Inc. (a subsidiary of Roche)
• IBM Corporation
• Tempus Labs Inc.
• Syneos Health Inc.
• Evidera, Inc.
• Palantir Technologies Inc.
• SAS Institute Inc.